Literature DB >> 16707517

Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis.

H J Kim1, C H Kang, Y T Kim, S-W Sung, J H Kim, S M Lee, C-G Yoo, C-T Lee, Y W Kim, S K Han, Y-S Shim, J-J Yim.   

Abstract

Although surgical lung resection could improve prognosis in some patients with multidrug-resistant tuberculosis (MDR-TB), there are no reports on the optimal candidates for this surgery. The aim of the present study was to elucidate the prognostic factors for surgery in patients with MDR-TB. Patients who underwent lung resection for the treatment of MDR-TB between March 1993 and December 2004 were included in the present study. Treatment failure was defined as greater than or equal to two of the five cultures recorded in the final 12 months of treatment being positive, any one of the final three cultures being positive, or the patient having died during treatment. The variables that affected treatment outcomes were identified through univariate and multivariate logistic regression analysis. In total, 79 patients with MDR-TB were included in the present study. The treatment outcomes of 22 (27.8%) patients were classified as failure. A body mass index <18.5 kg x m(-2), primary resistance, resistance to ofloxacin and the presence of a cavitary lesion beyond the range of the surgical resection were associated with treatment failure. Low body mass index, primary resistance, resistance to ofloxacin and cavitary lesions beyond the range of resection are possible poor prognostic factors for surgical lung resection in multidrug-resistant tuberculosis patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16707517     DOI: 10.1183/09031936.06.00023006

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

Review 1.  Surgical treatment of drug-resistant tuberculosis.

Authors:  Russell R Kempker; Sergo Vashakidze; Nelly Solomonia; Nino Dzidzikashvili; Henry M Blumberg
Journal:  Lancet Infect Dis       Date:  2012-02       Impact factor: 25.071

Review 2.  Post-resection complications: abscesses, empyemas, bronchopleural fistulas.

Authors:  Matthew Egyud; Kei Suzuki
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

3.  Clinical outcomes for multi- and extensively drug resistant tuberculosis patients with adjunctive resectional lung surgery in Beijing, China.

Authors:  Yan Ma; Yu Pang; Jian Du; Yuhong Liu; Liang Li; Weiwei Gao
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 4.  Surgery and pleuro-pulmonary tuberculosis: a scientific literature review.

Authors:  Dragan Subotic; Piotr Yablonskiy; Giorgia Sulis; Ioan Cordos; Danail Petrov; Rosella Centis; Lia D'Ambrosio; Giovanni Sotgiu; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

5.  High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.

Authors:  J C M Brust; N R Gandhi; H Carrara; G Osburn; N Padayatchi
Journal:  Int J Tuberc Lung Dis       Date:  2010-04       Impact factor: 2.373

6.  Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.

Authors:  Sergo Vashakidze; Shota Gogishvili; Ketino Nikolaishvili; Nino Dzidzikashvili; Nestani Tukvadze; Henry M Blumberg; Russell R Kempker
Journal:  Ann Thorac Surg       Date:  2013-05-01       Impact factor: 4.330

7.  Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.

Authors:  Jinwoo Lee; Chang-Hoon Lee; Deog Kyeom Kim; Ho Il Yoon; Jae Yeol Kim; Sang-Min Lee; Seok-Chul Yang; Jae Ho Lee; Chul-Gyu Yoo; Choon-Taek Lee; Hee Soon Chung; Young Whan Kim; Sung Koo Han; Jae-Joon Yim
Journal:  Korean J Intern Med       Date:  2011-06-01       Impact factor: 3.165

8.  Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series.

Authors:  Lin Wang; Fan Xia; Feng Li; Xueqin Qian; Yijun Zhu; Hui Chen; Aoao Bian; Jun Wang; Min Zhang; Hongwei Li; Jiafu Han; Nan Jiang; Ning Xu; Yanzheng Song
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  T CELL EPITOPES OF THE ESXA FULL GENE OF MYCOBACTERIUM TUBERCULOSIS FROM SPUTUM OF MDR-TB PATIENTS.

Authors:  Desak Nyoman Surya Suameitria Dewi; Ni Made Mertaniasih
Journal:  Afr J Infect Dis       Date:  2018-06-18

10.  SEVERITY OF TB CLASSIFIED BY MODIFIED BANDIM TB SCORING ASSOCIATES WITH THE SPECIFIC SEQUENCE OF ESXA GENES IN MDR-TB PATIENTS.

Authors:  Desak Nyoman Surya Suameitria Dewi; Ni Made Mertaniasih
Journal:  Afr J Infect Dis       Date:  2020-01-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.